RE:RE:Crew is better. Same with NuVista. This one is flat.Assuming things 'go wrong'.
We have $55 WCS USD & $68 condensate, plus C3 at 5 year highs. These are 3 products that Crew has a healthy mix off in their production (as does Kelt).
Crew will sell an asset like NuVista has done and the stock will re-rate immediately as did NuVista and Surge.
I like both Kelt and Crew, Crew will outperform in time from a stock perspective however.
stockfy wrote: Both Crew (CR) and Nuvista (NVA) have a lot of debt. They will be the next ones that will underperform when things go wrong.
DEE, CQE, BXE etc. have filed for bankruptcy lately due to the debt overhang.
The list with the bankrupt names due to the debt overhang is long.
Cheadle12 wrote:
No movement.. dropped from the highs, dissappointing reserves report that the street didn't care for..
now stagnant.
No catalysts it seems on the horizon.
With Crew's pending asset sales, no wonder it's more solid .. same with NuVista.. roared up on asset sale news.
Kelt it seems sold off their prized asset at the bottom of the market for much less than what it would be worth today.. that's a bad piece of business and they're now paying for it.